3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
2
Thyroid Neoplasms
1
Thoracic Neoplasms
1
Solid Tumors
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Neoplasms, Nerve Tissue
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Lung Diseases
1
Head and Neck Neoplasms
1
Carcinoma, Bronchogenic
1
Carcinoma
1
Bronchial Diseases
1
Advanced Thyroid Cancer Patients Who Received Target Therapy
1
Adenocarcinoma
1
Interventions
Bevacizumab
5
Cetuximab
3
palbociclib
2
encorafenib
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
tislelizumab
1
ribociclib
1
repotrectinib
1
olaparib
1
fludarabine
1
durvalumab
1
dostarlimab
1
atezolizumab
1
Tretinoin
1
Stem Cell Transplantation
1
Sirolimus
1
Ramucirumab
1
Radiotherapy
1
Paclitaxel
1
Oxaliplatin
1
Oviposition
1
Melphalan
1
Lutetium-177
1
Lutetium
1
Levoleucovorin
1
Injections
1
Immunotherapy
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Digestive System Neoplasms
×
pralsetinib
×
1 year
×
Clear all
No trials found.